Shanghai Labway Clinical Laboratory Co., Ltd.

Shenzhen Stock Exchange 301060.SZ

Shanghai Labway Clinical Laboratory Co., Ltd. Market Capitalization on January 27, 2025: USD 489.83 M

Shanghai Labway Clinical Laboratory Co., Ltd. Market Capitalization is USD 489.83 M on January 27, 2025, a -19.46% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Shanghai Labway Clinical Laboratory Co., Ltd. 52-week high Market Capitalization is USD 777.54 M on March 21, 2024, which is 58.74% above the current Market Capitalization.
Shanghai Labway Clinical Laboratory Co., Ltd. 52-week low Market Capitalization is USD 413.12 M on July 24, 2024, which is -15.66% below the current Market Capitalization.
Shanghai Labway Clinical Laboratory Co., Ltd. average Market Capitalization for the last 52 weeks is USD 537.49 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

Shenzhen Stock Exchange: 301060.SZ

Shanghai Labway Clinical Laboratory Co., Ltd.

CEO	Mr. Weixiong Zeng
IPO Date	Sept. 13, 2021
Location	China
Headquarters	Building 1, Lane 268
Employees	1,487
Sector	Healthcare
Industries Biotechnology Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Hardware & Electronics Personal Care Professional Services Specialty Retail

Description

Shanghai Labway Clinical Laboratory Co., Ltd. offers sales services for in vitro diagnostic products; and medical laboratory services. Shanghai Labway Clinical Laboratory Co., Ltd. was founded in 1993 and is based in Shanghai, China.

Key trends

Past 5 years